We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Zika Virus Persists Longer in Cutaneous Capillary Blood

By LabMedica International staff writers
Posted on 02 Nov 2017
Zika virus disease is caused by a virus transmitted primarily by Aedes mosquitoes. More...
People with Zika virus disease can have symptoms including mild fever, skin rash, conjunctivitis, muscle and joint pain, malaise or headache.

Zika virus, belonging to the family Flaviviridae and genus Flavivirus, is transmitted to humans by mosquito bites but can also be contracted through sexual and vertical transmission. As with other arboviruses, Zika virus viremia is commonly measured in venous blood, even though mosquitoes introduce virus into cutaneous capillary blood.

A team of scientists working with those at the Institut Pasteur de la Guyane (Cayenne, French Guiana) collected venous and capillary serum samples from 21 Zika virus‒infected patients on multiple days after symptom onset. They confirmed Zika virus infection by real-time reverse transcription polymerase chain reaction (RT-PCR) of serum and urine samples provided by patients during the first few days after symptom onset.

The team obtained serum samples from the venous and cutaneous capillary blood (collected from the fingertip) sequentially 1 to 18 days after the onset of symptoms. The median age of the population was 40 (range 28–63) years and the sex ratio, male:female was 1.6. They extracted RNA from 150-µL samples using the QIAamp Viral RNA kit and performed Zika virus RNA amplification using the RealStar Zika Virus RT-PCR Kit. They performed Zika virus RNA quantification using a reference strain and estimated the Zika virus RNA load as log10 copies/mL.

The scientists found that Zika virus RNA loads in capillary blood correlated with those in venous blood but were significantly higher in the capillary samples, except for three patients. The median duration of Zika virus detection after symptom onset was significantly greater in capillary blood than in venous blood, even though the duration of detection in capillary blood was underestimated; RNA was still detectable in the last capillary blood samples taken from eight patients. The duration of Zika virus RNA detection was greater in capillary than in venous blood for 12 of the 21 patients. The maximum duration of RNA detection in capillary blood samples was 18 days after the onset of symptoms with a load of 1.9 log10 copies/mL.

The authors concluded that if the Zika virus RNA observed in the serum samples taken from the capillary compartment reflects the presence of infectious virus particles, symptomatic Zika virus‒infected patients would need to be shielded from mosquitoes for a longer period than is currently practiced to limit potential vector-borne transmission. The study was published in the November 2017 edition of the journal Emerging Infectious Diseases.

Related Links:
Institut Pasteur de la Guyane


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
Clostridium Difficile Toxin A+B Combo Card Test
CerTest Clostridium Difficile Toxin A+B
New
Automated Biochemical Analyzer
iBC 900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.